Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics, Inc. Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics Inc. (FLGT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,531,801 | $28,292,364 | +21% | 0.01% |
| 2. | Park West Asset Management Peter S. Park | 641,682 | $11,851,867 | -11% | 0.95% |
| 3. | Invenomic Capital Management Ali Motamed | 259,010 | $4,783,915 | +4% | 0.22% |
| 4. | Citadel Investment Group Ken Griffin | 226,619 | $4,185,653 | -26% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 143,613 | $2,652,533 | -47% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.96 | 100,000 | 348,282 | 2025-03-05 | Filing | ||
| $4.95 | 8,739 | Large Shareholder, Officer, Director | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | Large Shareholder, Officer, Director | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | Large Shareholder, Officer, Director | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | Large Shareholder, Officer, Director | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.50 | 1,455 | 334,681 | 2024-12-03 | Filing | ||
| $19.50 | 1,373 | 919,469 | 2024-12-03 | Filing | ||
| $18.26 | 2,227 | 703,711 | 2024-11-25 | Filing | ||
| $18.26 | 497 | 920,842 | 2024-11-25 | Filing | ||
| $18.26 | 689 | 336,136 | 2024-11-25 | Filing |
Institutional Investors' Holdings
News See All
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
10 DNA Stocks Billionaires Are Loading Up On
Genomics is the study of a complete set of DNA within an organism.
Billionaire Hedge Funds
